oral liposomal compounded glp-1/gip Meet FOUNDAYO™ (Orforglipron)—the new FDA-approved GLP-1 weight loss medication. No injections. Just one convenient daily pill designed to help support long-term weight management when paired with healthy lifestyle changes. ✔️ Once-daily GLP-1/GIP Oral Drops - BeSpoke

Discover the newest breakthroughs in longevity The Psychological Fallout Is Real Surprisingly, for many people the emotional side effects of a missed dose last longer than the physical ones

After 12 months, patients taking Lillys drug saw nearly 7% more weight loss than those taking Novos

The FDA and FTC perspective Regulatory agencies have taken notice

Since the use of animal insulin for the treatment of diabetes in 1922, about nine major classes of drugs for the treatment of diabetes have been discovered and developed worldwide, including sulfonylureas, biguanides, -glucosidase inhibitors, insulins, thiazolidinediones (TZDs), meglitinides, GLP-1RAs, DPP-4 inhibitors, and SGLT-2 inhibitors

128-131 Antivirals have been theorized to be beneficial or evaluated in patients, with inconsistent results

In addition, lipid peroxidation also occurs through nonenzymatically spontaneous autoxidations (Lee et al., 2021)